WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark RELFINBI was filed as Word mark on 03/09/2022 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1657552 |
| Countries | 
|
| Base trademark |
No. 97021169,
September 10, 2021
|
| Application date | March 9, 2022 |
| Expiration date | March 9, 2032 |
Trademark owner
555 Long Wharf Drive, 12th Floor
New Haven CT 06516
US
New Haven CT 06516
US
Trademark representatives
1299 Pennsylvania Avenue NW,
Suite 700
US
goods and services
05
Pharmaceuticals for the treatment of central nervous system
disorders; pharmaceuticals for the treatment of neurological
and psychiatric disorders; pharmaceuticals for the treatment
of agitation; pharmaceuticals for the treatment of agitation
associated with neuropsychiatric conditions,
neurodegenerative diseases, schizophrenia, bipolar disorder,
dementia, delirium, alcohol withdrawal, opioid use disorder,
opioid withdrawal, substance abuse withdrawal, depression or
any other central nervous system disorder; pharmaceuticals
for the treatment of symptoms associated with alcohol
withdrawal, opioid use disorder, opioid withdrawal,
substance abuse withdrawal, depression or other central
nervous system disorders
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 7, 2023 | 2023/32 Gaz | CA | Rejection |
| March 10, 2023 | 2023/11 Gaz | CH | Rejection |
| February 16, 2023 | 2023/7 Gaz | JP | Rejection |
| September 7, 2022 | 2022/36 Gaz | EM | Rejection |
| July 27, 2022 | 2022/30 Gaz | GB | Rejection |
| July 5, 2022 | 2022/27 Gaz | AU | Rejection |
| March 9, 2022 | 2022/14 Gaz | US | Registration |
ID: 141657552